Meeder Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-272
| Closed | -$5.24K | – | 1012 |
|
|
2024
Q3 | $5.24K | Buy |
272
+59
| +28% | +$1.14K | ﹤0.01% | 735 |
|
|
2024
Q2 | $4.37K | Buy |
213
+27
| +15% | +$554 | ﹤0.01% | 794 |
|
|
2024
Q1 | $4.43K | Buy |
+186
| New | +$4.43K | ﹤0.01% | 646 |
|
|
2020
Q3 | – | Sell |
-59
| Closed | – | – | 2366 |
|
|
2020
Q2 | $0 | Sell |
59
-901
| -94% | – | ﹤0.01% | 2431 |
|
|
2020
Q1 | $11K | Sell |
960
-183
| -16% | -$2.1K | ﹤0.01% | 1484 |
|
|
2019
Q4 | $9K | Buy |
1,143
+520
| +83% | +$4.09K | ﹤0.01% | 1596 |
|
|
2019
Q3 | $5K | Buy |
623
+126
| +25% | +$1.01K | ﹤0.01% | 1776 |
|
|
2019
Q2 | $5K | Buy |
497
+246
| +98% | +$2.48K | ﹤0.01% | 1679 |
|
|
2019
Q1 | $1K | Buy |
+251
| New | +$1K | ﹤0.01% | 1641 |
|
|
2018
Q4 | – | Sell |
-202
| Closed | -$2K | – | 1793 |
|
|
2018
Q3 | $2K | Buy |
+202
| New | +$2K | ﹤0.01% | 1444 |
|
|
2018
Q2 | – | Sell |
-145
| Closed | -$2K | – | 1672 |
|
|
2018
Q1 | $2K | Buy |
+145
| New | +$2K | ﹤0.01% | 1393 |
|
|
2017
Q3 | – | Sell |
-219
| Closed | -$3K | – | 1750 |
|
|
2017
Q2 | $3K | Sell |
219
-3
| -1% | -$41 | ﹤0.01% | 1337 |
|
|
2017
Q1 | $3K | Buy |
222
+6
| +3% | +$81 | ﹤0.01% | 1278 |
|
|
2016
Q4 | $2K | Buy |
+216
| New | +$2K | ﹤0.01% | 937 |
|